Studies have shown that PD-1 on tumor-infiltrating lymphocytes (TILs) can bind with programmed death ligand-1 (PD-L1) on tumor cells, which subsequently inhibits T-cell proliferation and activation, leading to immune escape of tumor cells (41). The gene discussed is CD274; the disease is neoplasm.